The physiologic basis for combined nitroprusside-dopamine therapy in post-myocardial infarction heart failure.
D001794:Blood Pressure / Q000187:drug effects; D004298:Dopamine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005292:Ferricyanides / Q000008:administration & dosage*; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000150:complications*; D009206:Myocardium / Q000378:metabolism; D009599:Nitroprusside / Q000008:administration & dosage*; D010101:Oxygen Consumption / Q000187:drug effects; D013318:Stroke Volume / Q000187:drug effects
D005292:Ferricyanides; D009599:Nitroprusside; D004298:Dopamine